Horizon Therapeutics
HZNP
#740
Rank
A$42.54 B
Marketcap
$185.77
Share price
0.00%
Change (1 day)
14.81%
Change (1 year)

Horizon Therapeutics (HZNP) - Cash on Hand

Cash on Hand as of June 2023 : A$3.93 Billion

According to Horizon Therapeutics 's latest financial reports the company has A$3.93 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Horizon Therapeutics - Cash on Hand chart (from 2009 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$3.45 B58.61%
2021-12-31A$2.17 B-19.41%
2020-12-31A$2.70 B75.96%
2019-12-31A$1.53 B12.96%
2018-12-31A$1.36 B41.4%
2017-12-31A$0.96 B36.28%
2016-12-31A$0.70 B-40.15%
2015-12-31A$1.17 B341.35%
2014-12-31A$0.26 B196.32%
2013-12-31A$90.22 M-9.92%
2012-12-31A$0.10 B471.63%
2011-12-31A$17.52 M230.58%
2010-12-31A$5.3 M-33.5%
2009-12-31A$7.97 M-60.02%
2008-12-31A$19.93 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$14.39 B 265.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.87 B 100.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$15.89 B 303.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.20 B-69.43%๐Ÿ‡ฎ๐Ÿ‡ณ India
A$23.31 B 492.10%๐Ÿ‡บ๐Ÿ‡ธ USA